Development Level

Tbio 71 | 10,625
Tdark 19 | 7,003
Tchem 10 | 1,890
Tclin 8 | 602

IMPC Term

increased circulating sodium l... 2 | 71
abnormal retina morphology 1 | 100
abnormal retinal pigmentation 1 | 61
cardiovascular system phenotyp... 1 | 35
decreased T cell number 1 | 31
decreased circulating alanine ... 1 | 53
decreased circulating glucose ... 1 | 121
decreased eosinophil cell numb... 1 | 41
decreased heart rate variabili... 1 | 11
decreased monocyte cell number 1 | 28
decreased prepulse inhibition 1 | 52
enlarged heart 1 | 111
increased CD4-positive, alpha ... 1 | 15
increased leukocyte cell numbe... 1 | 37
increased startle reflex 1 | 38
preweaning lethality, incomple... 1 | 260
shortened RR interval 1 | 19

Disease

psoriasis 42 | 6,685
lung cancer 40 | 4,473
ovarian cancer 40 | 8,492
Rheumatoid Arthritis 38 | 1,171
invasive ductal carcinoma 33 | 2,950
lung carcinoma 31 | 2,844
glioblastoma 27 | 5,572
lung adenocarcinoma 27 | 2,714
diabetes mellitus 26 | 1,663
non-small cell lung cancer 26 | 2,798
osteosarcoma 24 | 7,933
breast carcinoma 23 | 1,614
intraductal papillary-mucinous carcinoma (IPMC) 23 | 2,988
Multiple Sclerosis 22 | 498
tuberculosis 22 | 1,563
Breast cancer 21 | 3,099
Cancer 21 | 2,346
pilocytic astrocytoma 21 | 3,086
sarcoidosis 21 | 368
systemic lupus erythematosus 21 | 172
ulcerative colitis 20 | 2,087
cutaneous lupus erythematosus 19 | 1,056
dermatomyositis 19 | 967
intraductal papillary-mucinous neoplasm (IPMN) 19 | 3,289
pancreatic cancer 19 | 2,300
subependymal giant cell astrocytoma 19 | 2,287
malignant mesothelioma 18 | 3,163
Berylliosis 17 | 28
Narcolepsy 17 | 69
cystic fibrosis 17 | 1,670
interstitial cystitis 17 | 2,299
medulloblastoma, large-cell 17 | 6,234
Hypersensitivity reaction type II disease 16 | 235
intraductal papillary-mucinous adenoma (IPMA) 16 | 2,956
Asthma 15 | 349
Lupus erythematosus 14 | 80
Multiple Sclerosis, Susceptibility to 14 | 15
Multiple myeloma 14 | 1,328
Narcolepsy-cataplexy 14 | 21
colon cancer 14 | 1,475
ductal carcinoma in situ 14 | 1,745
pancreatic ductal adenocarcinoma liver metastasis 14 | 1,795
Diffuse cutaneous systemic sclerosis 13 | 17
Rheumatoid Arthritis, Systemic Juvenile 13 | 16
Sarcoidosis 1 13 | 14
adrenocortical carcinoma 13 | 1,427
follicular lymphoma 13 | 17
juvenile dermatomyositis 13 | 1,189
limited scleroderma 13 | 19
primary Sjogren syndrome 13 | 789
Duchenne muscular dystrophy 12 | 602
Type 1 diabetes mellitus 12 | 104
Vasculitis 12 | 64
atypical teratoid / rhabdoid tumor 12 | 4,369
Kidney disease 11 | 397
Waldenstrons macroglobulinemia 11 | 765
astrocytoma 11 | 1,493
Hepatitis B 10 | 103
Liver disease 10 | 219
active Crohn's disease 10 | 918
acute quadriplegic myopathy 10 | 1,157
head and neck cancer and chronic obstructive pulmonary disease 10 | 237
non-small cell lung carcinoma 10 | 413
pancreatic carcinoma 10 | 567
posterior fossa group A ependymoma 10 | 1,511
Anemia 9 | 252
Complement deficiency 9 | 15
Inflammatory bowel disease 9 | 142
Leishmaniasis 9 | 49
Meningitis 9 | 46
esophageal adenocarcinoma 9 | 737
group 4 medulloblastoma 9 | 1,875
pediatric high grade glioma 9 | 2,712
Becker muscular dystrophy 8 | 187
Connective tissue disease 8 | 59
Dermatitis 8 | 141
Down syndrome 8 | 548
Hypersensitivity 8 | 63
Influenza 8 | 142
Lupus Erythematosus, Systemic 8 | 73
Tetanus 8 | 66
acute myeloid leukemia 8 | 785
group 3 medulloblastoma 8 | 2,254
hepatocellular carcinoma 8 | 550
inflammatory breast cancer 8 | 404
pituitary cancer 8 | 1,972
primary pancreatic ductal adenocarcinoma 8 | 1,271
Allergic hypersensitivity disease 7 | 123
Arthritis 7 | 248
Diabetes Mellitus, Insulin-Dependent 7 | 77
Endometriosis 7 | 535
Human immunodeficiency virus infectious disease 7 | 129
IGA Glomerulonephritis 7 | 454
Lung disease 7 | 136
Malaria 7 | 140
Primary immunodeficiency disease 7 | 52
Thrombocytopenia 7 | 105
adult high grade glioma 7 | 2,148
periodontitis 7 | 269
sonic hedgehog group medulloblastoma 7 | 1,482

Tissue

Female tissues 97 | 18,647
Male tissues 96 | 17,969
Blood and immune system 95 | 17,995
Endocrine System 95 | 18,512
Nervous System 95 | 18,561
Urinary Tract 95 | 18,444
Cardiovascular System 94 | 17,958
Digestive Tract 94 | 18,473
Liver and Pancreas 94 | 18,136
Respiratory system 93 | 17,484
Skin and soft tissues 80 | 18,115

Target Family

Non-IDG 103 | 11,969
Enzyme 3 | 4,146
Ion Channel 2 | 341

KEGG Pathway

Systemic lupus erythematosus 108 | 108
Metabolic pathways 1,254 | 1,254
Olfactory transduction 412 | 412
Pathways in cancer 402 | 402
HTLV-I infection 339 | 339
PI3K-Akt signaling pathway 338 | 338
Endocytosis 326 | 326
Epstein-Barr virus infection 279 | 279
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 262 | 262
Herpes simplex infection 262 | 262
MAPK signaling pathway 255 | 255
Viral carcinogenesis 253 | 253
Phagosome 231 | 231
Cell adhesion molecules (CAMs) 225 | 225
Ras signaling pathway 225 | 225
Rap1 signaling pathway 213 | 213
Regulation of actin cytoskelet... 213 | 213
Proteoglycans in cancer 202 | 202
cAMP signaling pathway 201 | 201
Focal adhesion 200 | 200
Natural killer cell mediated c... 199 | 199
Huntington's disease 194 | 194
Tuberculosis 187 | 187
Influenza A 184 | 184
Chemokine signaling pathway 182 | 182
Calcium signaling pathway 181 | 181
Axon guidance 176 | 176
Purine metabolism 171 | 171
Alzheimer's disease 169 | 169
Tight junction 169 | 169
NOD-like receptor signaling pa... 168 | 168
Protein processing in endoplas... 165 | 165
Transcriptional misregulation ... 165 | 165
cGMP-PKG signaling pathway 165 | 165
RNA transport 164 | 164
Oxytocin signaling pathway 158 | 158
Jak-STAT signaling pathway 157 | 157
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
mTOR signaling pathway 153 | 153
Non-alcoholic fatty liver dise... 151 | 151
Adrenergic signaling in cardio... 150 | 150
MicroRNAs in cancer 150 | 150
Breast cancer 146 | 146
Alcoholism 145 | 145
Hepatitis B 145 | 145
Phospholipase D signaling path... 145 | 145
Parkinson's disease 142 | 142
Wnt signaling pathway 142 | 142
Signaling pathways regulating ... 141 | 141
Apoptosis 140 | 140
Insulin signaling pathway 138 | 138
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Measles 135 | 135
Ribosome 134 | 134
Oxidative phosphorylation 133 | 133
FoxO signaling pathway 132 | 132
Hepatitis C 132 | 132
Spliceosome 132 | 132
Dopaminergic synapse 131 | 131
Osteoclast differentiation 131 | 131
Autoimmune thyroid disease 130 | 130
Toxoplasmosis 130 | 130
Cell cycle 125 | 125
Platelet activation 124 | 124
AMPK signaling pathway 123 | 123
Lysosome 123 | 123
Type I diabetes mellitus 122 | 122
Vascular smooth muscle contrac... 121 | 121
Graft-versus-host disease 120 | 120
Sphingolipid signaling pathway 120 | 120
Neurotrophin signaling pathway 119 | 119
Oocyte meiosis 119 | 119
Th17 cell differentiation 119 | 119
Thyroid hormone signaling path... 118 | 118
Allograft rejection 116 | 116
Glutamatergic synapse 116 | 116
Leukocyte transendothelial mig... 116 | 116
Carbon metabolism 114 | 114
Serotonergic synapse 114 | 114
Cholinergic synapse 110 | 110
TNF signaling pathway 110 | 110
Insulin resistance 109 | 109
Hematopoietic cell lineage 108 | 108
Chagas disease (American trypa... 106 | 106
T cell receptor signaling path... 104 | 104
Th1 and Th2 cell differentiati... 104 | 104
Glucagon signaling pathway 103 | 103
HIF-1 signaling pathway 103 | 103
Toll-like receptor signaling p... 103 | 103
Melanogenesis 102 | 102
Pyrimidine metabolism 102 | 102
AGE-RAGE signaling pathway in ... 101 | 101
Endocrine resistance 101 | 101
Estrogen signaling pathway 101 | 101
Retrograde endocannabinoid sig... 101 | 101
Amoebiasis 100 | 100
Rheumatoid arthritis 100 | 100

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
HLA class II histocompatibility antigen, DP beta 1 chain HLA-DPB1 Tbio Non-IDG -2.67719 572.7 274
CD40 ligand CD40LG Tchem Non-IDG -4.56976 36580.5 1095
Histone H2A.J H2AFJ Tdark Non-IDG -0.03378 0.61 90
Histone H2A type 1-J HIST1H2AJ Tdark Non-IDG -0.13212 1.19 10
Histone H2B type 1-M HIST1H2BM Tdark Non-IDG 0.16 0.33 20
Histone H2B type 1-N HIST1H2BN Tdark Non-IDG -1.51554 30.2 48
Histone H2B type 1-L HIST1H2BL Tdark Non-IDG 0.35 0.40 42
Histone H2A type 1-A HIST1H2AA Tbio Non-IDG -0.88903 7.62 60
Complement C3 C3 Tbio Non-IDG -3.54548 3337.1 965
Complement C5 C5 Tclin Non-IDG -2.22372 154.9 317